{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:47:16Z","timestamp":1791406036255,"version":"4.3.3"},"reference-count":130,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geburtshilfe Frauenheilkd"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Purpose This is an official guideline, published and coordinated by the Germany Society for Gynecology and Obstetrics (Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, DGGG).\n\t\t\t\t\tBecause of their rarity and heterogeneous histopathology, uterine sarcomas are challenging in terms of their clinical management and therefore require a multidisciplinary approach. To our\n\t\t\t\t\tknowledge, there are currently no binding evidence-based recommendations for the appropriate management of this heterogeneous group of tumors.<\/jats:p><jats:p>\n          Methods This S2k guideline was first published in 2015. The update published here is once again the result of the consensus of a representative interdisciplinary committee of experts\n\t\t\t\t\twho were commissioned by the Guidelines Committee of the DGGG to carry out a systematic search of the literature on uterine sarcomas. Members of the participating professional societies\n\t\t\t\t\tachieved a formal consensus after a structured consensus process.<\/jats:p><jats:p>\n          Recommendations 1.1 Epidemiology, classification, staging of uterine sarcomas. 1.2 Symptoms, general diagnostic workup, general pathology or genetic predisposition to uterine\n\t\t\t\t\tsarcomas. 2. Management of leiomyosarcomas. 3. Management of low-grade endometrial stromal sarcomas. 4. Management of high-grade endometrial stromal sarcoma and undifferentiated uterine\n\t\t\t\t\tsarcomas. 5. Management of adenosarcomas. 6.\u00a0Rhabdomyosarcomas of the uterus in children and adolescents. 7. Follow-up of uterine sarcomas. 8. Management of morcellated uterine sarcomas. 9.\n\t\t\t\t\tInformation provided to patients.<\/jats:p>","DOI":"10.1055\/a-1897-5124","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T23:48:57Z","timestamp":1669938537000},"page":"1337-1367","source":"Crossref","is-referenced-by-count":19,"title":["Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No.\u2009015\/074, April 2021)"],"prefix":"10.1055","volume":"82","author":[{"given":"Dominik","family":"Denschlag","sequence":"additional","affiliation":[{"name":"Frauenklinik, Hochtaunuskliniken Bad Homburg, Bad Homburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Ackermann","sequence":"additional","affiliation":[{"name":"Frauenklinik, Klinikum Darmstadt, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Johannes","family":"Battista","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsmedizin Mainz, Klinik und Poliklinik f\u00fcr Geburtshilfe und Frauengesundheit, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Cremer","sequence":"additional","affiliation":[{"name":"Berufsverband der Frauen\u00e4rzte, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Egerer","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Fehr","sequence":"additional","affiliation":[{"name":"Kantonsspital Frauenfeld, Frauenfeld, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Follmann","sequence":"additional","affiliation":[{"name":"Deutsche Krebsgesellschaft, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Haase","sequence":"additional","affiliation":[{"name":"Frauenselbsthilfe nach Krebs e.\u200aV., Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gyn\u00e4kologie und Gyn\u00e4kologische Onkologie, Kliniken Essen Mitte, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Hettmer","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Christian","family":"Horn","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Mamma-, Urogenital, und Perinatalpathologie, Institut f\u00fcr Pathologie, Universit\u00e4tsklinikum Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingolf","family":"Juhasz-Boess","sequence":"additional","affiliation":[{"name":"Frauenklinik, Universit\u00e4tsklinikum Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Kast","sequence":"additional","affiliation":[{"name":"Nationales Zentrum f\u00fcr Famili\u00e4re Tumorerkrankungen (NCFT), Universit\u00e4tsklinikum K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"K\u00f6hler","sequence":"additional","affiliation":[{"name":"Deutsches klinisches Kompetenzzentrum f\u00fcr genitale Sarkome und Mischtumoren, Universit\u00e4tsmedizin Greifswald, Greifswald, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kr\u00f6ncke","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Radiologie, Klinikum Augsburg, Augsburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lindel","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Radioonkologie, Klinikum Karlsruhe, Karlsruhe, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mallmann","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Frauenheilkunde und Geburtshilfe, Universit\u00e4tsklinikum K\u00f6ln, K\u00f6ln, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Meyer-Steinacker","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mustea","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gyn\u00e4kologie und Gyn\u00e4kologische Onkologie, Universit\u00e4tsklinikum Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Petru","sequence":"additional","affiliation":[{"name":"Univ. Klinik f\u00fcr Frauenheilkunde und Geburtshilfe der Medizinischen Universit\u00e4t Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reichardt","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr interdisziplin\u00e4re Onkologie, Helios Kliniken Berlin-Buch, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Schmidt","sequence":"additional","affiliation":[{"name":"MVZ f\u00fcr Histologie, Zytologie und Molekulare Diagnostik, Trier, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Strauss","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Gyn\u00e4kologie, Universit\u00e4tsklinikum Halle, Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Thiel","sequence":"additional","affiliation":[{"name":"Frauenklinik, Alb Fils Kliniken, G\u00f6ppingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Andreas","family":"Ulrich","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gyn\u00e4kologie und Geburtshilfe, Martin Luther Krankenhaus Berlin, Johannesstift Diakonie, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr diagnostische und interventionelle Radiologie, Universit\u00e4tsklinikum Frankfurt, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vordermark","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik und Poliklinik f\u00fcr Strahlentherapie, Universit\u00e4tsklinikum Halle, Halle\/Saale, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wallwiener","sequence":"additional","affiliation":[{"name":"Frauenklinik, Universit\u00e4tsklinikum Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gass","sequence":"additional","affiliation":[{"name":"Frauenklinik des Universit\u00e4tsklinikums Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center Erlangen\/Europ\u00e4ische Metropolregion N\u00fcrnberg\n\t\t\t\t\t(CCC ER-EMN), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[{"name":"Frauenklinik des Universit\u00e4tsklinikums Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Comprehensive Cancer Center Erlangen\/Europ\u00e4ische Metropolregion N\u00fcrnberg\n\t\t\t\t\t(CCC ER-EMN), Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"ref1","volume-title":"TNM-Klassifikation maligner Tumoren","author":"C Wittekind","year":"2010"},{"key":"ref2","first-page":"135","volume-title":"Mesenchymal Tumors of the Uterus","author":"E Oliva","year":"2014"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAP.0000000000000046","article-title":"Endometrial stromal tumors: the new WHO classification","volume":"21","author":"C M Conklin","year":"2014","journal-title":"Adv Anat Pathol"},{"key":"ref4","volume-title":"WHO Classification of soft Tissue and Bone","author":"C DM Fletcher","year":"2013"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/IGC.0000000000000911","article-title":"European Society of Gynecological Oncology Statement on Fibroid and Uterine Morcellation","volume":"27","author":"M J Halaska","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13008","article-title":"Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study","volume":"95","author":"M Skorstad","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejogrb.2017.10.030","article-title":"Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations","volume":"220","author":"O Sizzi","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00404-019-05344-0","article-title":"Benign uterine mass-discrimination from leiomyosarcoma by a preoperative risk score: a multicenter cohort study","volume":"300","author":"G Kohler","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","article-title":"The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma","volume":"122","author":"J Y Park","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","article-title":"Clinical management of uterine sarcomas","volume":"10","author":"F Amant","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.5858\/2005-129-1544-ICIGP","article-title":"Intraoperative consultation in gynecologic pathology","volume":"129","author":"D Coffey","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/cncr.26390","article-title":"Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database","volume":"118","author":"S Ognjanovic","year":"2012","journal-title":"Cancer"},{"key":"ref15","first-page":"5358","article-title":"A cancer family syndrome in twenty-four kindreds","volume":"48","author":"F P Li","year":"1988","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2012.01.021","article-title":"Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases","volume":"72","author":"R Koivisto-Korander","year":"2012","journal-title":"Maturitas"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-0489-8_10","volume-title":"Mesenchymal Tumors of the Uterus","author":"C J Zaloudek","year":"2011"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bpobgyn.2011.07.003","article-title":"Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential","volume":"25","author":"P P Ip","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00000478-199704000-00003","article-title":"Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients","volume":"21","author":"R A Prayson","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"ref20","volume-title":"WHO Classification of Tumours Editorial Board. WHO Classification of Tumours of Soft Tissue and Bone. 5th ed","year":"2020"},{"issue":"S 01","key":"ref21","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/modpathol.2015.139","article-title":"Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia","volume":"29","author":"E Oliva","year":"2016","journal-title":"Mod Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/IGC.0b013e3181a1bfbc","article-title":"Prognostic factors in early-stage leiomyosarcoma of the uterus","volume":"19","author":"M Pelmus","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cncr.27971","article-title":"External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma","volume":"119","author":"A Iasonos","year":"2013","journal-title":"Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/IGC.0b013e3181dc8292","article-title":"Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes","volume":"20","author":"G Garg","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jmig.2014.08.781","article-title":"Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review","volume":"22","author":"E A Pritts","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.23245","article-title":"Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy","volume":"112","author":"D S Kapp","year":"2008","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.3802\/jgo.2017.28.e46","article-title":"Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma","volume":"28","author":"D Nasioudis","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-8258(03)00478-5","article-title":"Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus","volume":"91","author":"M M Leitao","year":"2003","journal-title":"Gynecol Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study","volume":"145","author":"B L Seagle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ygyno.2016.07.110","article-title":"Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis","volume":"143","author":"G Bogani","year":"2016","journal-title":"Gynecol Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ygyno.2019.07.001","article-title":"Effect of adjuvant therapy on the risk of recurrence in early-stage leiomyosarcoma: A meta-analysis","volume":"154","author":"S H Chae","year":"2019","journal-title":"Gynecol Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mds545","article-title":"A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine\n\t\t\t\t\tsarcomas (SARCGYN study). A study of the French Sarcoma Group","volume":"24","author":"P Pautier","year":"2013","journal-title":"Ann Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2008.11.027","article-title":"Adjuvant gemcitabine plus docetaxel for completely resected stages I\u2013IV high grade uterine leiomyosarcoma: Results of a prospective study","volume":"112","author":"M L Hensley","year":"2009","journal-title":"Gynecol Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/cncr.27942","article-title":"Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC005)","volume":"119","author":"M L Hensley","year":"2013","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00454","article-title":"Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology\/Gynecologic Oncology Group Study","author":"M L Hensley","year":"2018","journal-title":"J Clin Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of\n\t\t\t\t\tCancer Gynaecological Cancer Group Study (protocol 55874)","volume":"44","author":"N S Reed","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/IGC.0b013e3181c9e289","article-title":"Metastatic uterine leiomyosarcomas: a single-institution experience","volume":"20","author":"R Bernstein-Molho","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.2002.6840","article-title":"Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma","volume":"87","author":"M M Leitao","year":"2002","journal-title":"Gynecol Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0090-8258(92)90286-R","article-title":"Resection of pulmonary metastases from uterine sarcomas","volume":"45","author":"C Levenback","year":"1992","journal-title":"Gynecol Oncol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1072-7515(00)00306-9","article-title":"Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma","volume":"191","author":"M R Weiser","year":"2000","journal-title":"J Am Coll Surg"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma","volume":"106","author":"E Garrett-Mayer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jtcvs.2003.10.011","article-title":"Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients","volume":"127","author":"M Anraku","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1091-255X(98)80006-1","article-title":"Complete hepatic resection of metastases from leiomyosarcoma prolongs survival","volume":"2","author":"H Chen","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ygyno.2019.05.015","article-title":"Secondary surgical resection for patients with recurrent uterine leiomyosarcoma","volume":"154","author":"P Cybulska","year":"2019","journal-title":"Gynecol Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9378(92)91671-V","article-title":"Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"166","author":"G P Sutton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2003.11.023","article-title":"Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study","volume":"92","author":"K Y Look","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/gyno.1996.0289","article-title":"Phase II trial of etoposide in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"63","author":"T Thigpen","year":"1996","journal-title":"Gynecol Oncol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/gyno.1998.5080","article-title":"Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study","volume":"70","author":"P G Rose","year":"1998","journal-title":"Gynecol Oncol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000421-200008000-00009","article-title":"Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study","volume":"23","author":"D S Miller","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0090-8258(02)00136-1","article-title":"Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study","volume":"89","author":"D G Gallup","year":"2003","journal-title":"Gynecol Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1996.0220","article-title":"Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study","volume":"62","author":"G Sutton","year":"1996","journal-title":"Gynecol Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial","volume":"20","author":"M L Hensley","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clon.2012.11.008","article-title":"Systematic chemotherapy for inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a systematic review","volume":"25","author":"A A Gupta","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","article-title":"Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through\n\t\t\t\t\tcollaboration study 002 [corrected]","volume":"25","author":"R G Maki","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","article-title":"Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale\n\t\t\t\t\tdes Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)","volume":"17","author":"P Pautier","year":"2012","journal-title":"Oncologist"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled\n\t\t\t\t\tphase 3 trial","volume":"18","author":"B Seddon","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2008.21.0088","article-title":"Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase\n\t\t\t\t\tII study of two different schedules","volume":"27","author":"G D Demetri","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"W T van der Graaf","year":"2012","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PGP.0000000000000141","article-title":"Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations","volume":"33","author":"E Oliva","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAP.0b013e3181cfb7c2","article-title":"Endometrial stromal sarcomas: a review of potential prognostic factors","volume":"17","author":"I Chew","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00000478-199005000-00002","article-title":"Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases","volume":"14","author":"K L Chang","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/IGC.0b013e3181b33c9a","article-title":"Does radiotherapy or lymphadenectomy improve survival in endometrial stromal sarcoma?","volume":"19","author":"B Barney","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00428-018-2358-5","article-title":"Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma","volume":"473","author":"J Y Park","year":"2018","journal-title":"Virchows Arch"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0090-8258(03)00258-0","article-title":"Low-grade endometrial stromal sarcoma: hormonal aspects","volume":"90","author":"M C Chu","year":"2003","journal-title":"Gynecol Oncol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1525-1438.2007.01126.x","article-title":"Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease","volume":"18","author":"M H Einstein","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/ijgc-2018-000063","article-title":"Ovarian preservation for low-grade endometrial stromal sarcoma: a systematic review of the literature and meta-analysis","volume":"29","author":"D Nasioudis","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/sj.bjc.6604527","article-title":"Endometrial stromal sarcoma: a population-based analysis","volume":"99","author":"J K Chan","year":"2008","journal-title":"Br J Cancer"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2013.12.032","article-title":"Ovary and uterus-sparing procedures for low-grade endometrial stromal sarcoma: a retrospective study of 153 cases","volume":"132","author":"H Bai","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/AOG.0b013e31818aa89a","article-title":"Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma","volume":"112","author":"J P Shah","year":"2008","journal-title":"Obstet Gynecol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/IGC.0000000000000842","article-title":"Role of Lymphadenectomy for Uterine Sarcoma: A Meta-Analysis","volume":"27","author":"M Si","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00404-019-05308-4","article-title":"The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis","volume":"300","author":"R Cui","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.critrevonc.2007.06.011","article-title":"The management of patients with uterine sarcoma: a debated clinical challenge","volume":"65","author":"A Gadducci","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/IGC.0000000000000557","article-title":"Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma","volume":"25","author":"M Yamaguchi","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/sj.bjc.6603986","article-title":"Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma","volume":"97","author":"F Amant","year":"2007","journal-title":"Br J Cancer"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijrobp.2009.02.077","article-title":"The role of adjuvant radiation in uterine sarcomas","volume":"76","author":"S Sampath","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref76","first-page":"173","article-title":"Uterine endolymphatic stromal myosis: a collaborative study","volume":"64","author":"M S Piver","year":"1984","journal-title":"Obstet Gynecol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bpobgyn.2011.05.009","article-title":"Surgical treatment of uterine sarcoma","volume":"25","author":"J H Nam","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ygyno.2010.12.360","article-title":"Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy","volume":"121","author":"X Cheng","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejogrb.2009.02.005","article-title":"The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study","volume":"144","author":"T Dahhan","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/gyno.2001.6238","article-title":"Endometrial stromal sarcoma: objective response to letrozole","volume":"82","author":"F C Maluf","year":"2001","journal-title":"Gynecol Oncol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygyno.2005.11.010","article-title":"Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature","volume":"101","author":"D Pink","year":"2006","journal-title":"Gynecol Oncol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13569-015-0024-0","article-title":"Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital","volume":"5","author":"E Thanopoulou","year":"2015","journal-title":"Clin Sarcoma Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(00)01369-9","article-title":"Radiation therapy in the treatment of endometrial stromal sarcoma","volume":"49","author":"H D Weitmann","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00066-006-1491-2","article-title":"Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus","volume":"182","author":"B Kortmann","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/IJWH.S117754","article-title":"Uterine sarcoma \u2013 current perspectives","volume":"9","author":"C Benson","year":"2017","journal-title":"Int J Womens Health"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/ijc.29141","article-title":"A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of\n\t\t\t\t\tsurvival","volume":"136","author":"G Gremel","year":"2015","journal-title":"Int J Cancer"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/PAS.0000000000000894","article-title":"Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas","volume":"41","author":"E Hardell","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijgo.2013.01.025","article-title":"Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy","volume":"122","author":"G G Malouf","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2012.06.030","article-title":"High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes","volume":"127","author":"E J Tanner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/ijgc-2018-000064","article-title":"Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group","volume":"29","author":"M Meurer","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"e757","DOI":"10.1016\/j.ijrobp.2011.11.005","article-title":"Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study","volume":"82","author":"U Schick","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1177\/1066896918794278","article-title":"Extrapelvic Metastases in Endometrial Stromal Sarcomas: A Clinicopathological Review With Immunohistochemical and Molecular Characterization","author":"N Baniak","year":"2018","journal-title":"Int J Surg Pathol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jpag.2008.06.001","article-title":"Mullerian adenosarcoma of the cervix in a 10-year-old girl: case report and review of the literature","volume":"22","author":"N A Fleming","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.7150\/jca.30691","article-title":"Low-Grade Endometrial Stromal Sarcoma and Uterine Adenosarcoma: A Comparison of Clinical Manifestations and Outcomes","volume":"10","author":"Y Zhang","year":"2019","journal-title":"J Cancer"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/ajco.12859","article-title":"Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management","volume":"14","author":"K Tate","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/PAP.0b013e3181cfe732","article-title":"Mullerian adenosarcoma of the female genital tract","volume":"17","author":"W G McCluggage","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"ref97","volume-title":"WHO Classification of Tumours of female reproductive Tract \u2013 mixed epithelial and mesenchymal Tumors of the Uterus","author":"M Wells","year":"2014"},{"issue":"S 01","key":"ref98","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1038\/modpathol.2015.137","article-title":"A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus","volume":"29","author":"W G McCluggage","year":"2016","journal-title":"Mod Pathol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.path.2019.01.004","article-title":"Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features","volume":"12","author":"C Parra-Herran","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2016.10.013","article-title":"Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study","volume":"143","author":"B L Seagle","year":"2016","journal-title":"Gynecol Oncol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"4680273","DOI":"10.1155\/2017\/4680273","article-title":"Treatment of Recurrent or Metastatic Uterine Adenosarcoma","volume":"2017","author":"M J Nathenson","year":"2017","journal-title":"Sarcoma"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2012.12.036","article-title":"Management of uterine adenosarcomas with and without sarcomatous overgrowth","volume":"129","author":"E J Tanner","year":"2013","journal-title":"Gynecol Oncol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"e27096","DOI":"10.1002\/pbc.27096","article-title":"Localized vaginal\/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups","volume":"65","author":"V Minard-Colin","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/COC.0b013e31826b98e4","article-title":"Outcome of female pediatric patients diagnosed with genital tract rhabdomyosarcoma based on analysis of cases registered in SEER database between 1973 and 2006","volume":"37","author":"C H Kirsch","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1200\/JCO.1999.17.7.2117","article-title":"Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: A report from the Study Committee of the International Society of Pediatric Oncology","volume":"17","author":"H Martelli","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0035-1545684","article-title":"Surgical Methods for the Treatment of Uterine Fibroids \u2013 Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG","volume":"75","author":"M W Beckmann","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1634\/theoncologist.2014-0361","article-title":"Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma","volume":"20","author":"A S Brohl","year":"2015","journal-title":"Oncologist"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/IGC.0000000000000988","article-title":"Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany","volume":"27","author":"S Kundu","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00404-015-3696-z","article-title":"Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH)","volume":"292","author":"B Bojahr","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.2147\/CMAR.S208405","article-title":"Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients","volume":"11","author":"H Cao","year":"2019","journal-title":"Cancer Manag Res"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1701-2163(15)30366-2","article-title":"RETIRED: Technical update on tissue morcellation during gynaecologic surgery: its uses, complications, and risks of unsuspected malignancy","volume":"37","author":"S S Singh","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis","volume":"137","author":"G Bogani","year":"2015","journal-title":"Gynecol Oncol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"S George","year":"2014","journal-title":"Cancer"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","article-title":"Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study","volume":"144","author":"F Raspagliesi","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation","volume":"127","author":"T Raine-Bennett","year":"2016","journal-title":"Obstet Gynecol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tjog.2015.03.001","article-title":"Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma","volume":"54","author":"K H Lin","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00404-016-4086-x","article-title":"Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma","volume":"294","author":"W Nemec","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s12885-016-2727-x","article-title":"Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease","volume":"16","author":"J Y Lee","year":"2016","journal-title":"BMC Cancer"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"e0153996","DOI":"10.1371\/journal.pone.0153996","article-title":"Correction: A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma","volume":"11","author":"Z Gao","year":"2016","journal-title":"PloS One"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"e0148050","DOI":"10.1371\/journal.pone.0148050","article-title":"A Retrospective Analysis of the Impact of Myomectomy on Survival in Uterine Sarcoma","volume":"11","author":"Z Gao","year":"2016","journal-title":"PloS One"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jmig.2017.01.025","article-title":"Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation","volume":"24","author":"M Wasson","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/IGC.0000000000000638","article-title":"Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation","volume":"26","author":"J Zhang","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00404-015-3664-7","article-title":"Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques","volume":"292","author":"F Ebner","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12885-020-07003-z","article-title":"Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid","volume":"20","author":"G Zhang","year":"2020","journal-title":"BMC Cancer"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s40064-015-1318-7","article-title":"Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass","volume":"4","author":"T Nagai","year":"2015","journal-title":"SpringerPlus"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma","volume":"20","author":"D L Wickerham","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome","volume":"354","author":"K M Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000449157","article-title":"Novel Technique for Contained Power Morcellation through Umbilicus with Insufflated Bag","volume":"82","author":"M A Leal","year":"2017","journal-title":"Gynecol Obstet Invest"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jmig.2014.07.007","article-title":"The Sydney Contained In Bag Morcellation technique","volume":"21","author":"J B McKenna","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000477171","article-title":"Can In-Bag Manual Morcellation Represent an Alternative to Uncontained Power Morcellation in Laparoscopic Myomectomy? A Randomized Controlled Trial","volume":"83","author":"C Frasca","year":"2018","journal-title":"Gynecol Obstet Invest"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2015.12.133","article-title":"In-bag manual versus uncontained power morcellation for laparoscopic myomectomy: randomized controlled trial","volume":"105","author":"R Venturella","year":"2016","journal-title":"Fertil Steril"},{"issue":"05","key":"ref136","first-page":"CD013352","article-title":"In-bag manual versus uncontained power morcellation for laparoscopic myomectomy","author":"F Zullo","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Geburtshilfe und Frauenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1897-5124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T11:50:54Z","timestamp":1676029854000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1897-5124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":130,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1897-5124","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0016-5751","1438-8804"],"issn-type":[{"value":"0016-5751","type":"print"},{"value":"1438-8804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}